Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Dermatology

Starting Your Journey with Chanarin-Dorfman Syndrome

At a Glance

Chanarin-Dorfman syndrome is a rare inherited disorder caused by ABHD5 variants that lead to fat buildup in cells. Care focuses on protecting the skin barrier, monitoring organs such as the liver, and coordinating specialist support; dietary changes need expert supervision.

Receiving a diagnosis of Chanarin-Dorfman Syndrome (CDS) often brings a mix of relief and overwhelming uncertainty. You may have spent years visiting different specialists, trying various treatments for what appeared to be more common skin conditions, only to find they didn’t quite fit [1].

This page is designed to help you navigate the early days of this diagnosis, explaining what is happening inside the body and validating the unique challenges of living with a condition that few people—including many doctors—have seen before.

Understanding Your Diagnosis

Chanarin-Dorfman Syndrome, also known as Neutral Lipid Storage Disease with Ichthyosis (NLSDI), is an extremely rare genetic condition. Because there are only a limited number of cases documented in medical literature worldwide, it is very likely that your local healthcare team has never encountered it [2][3].

This rarity often leads to a “diagnostic odyssey,” where patients are misdiagnosed for years with more common conditions like pityriasis rubra pilaris (a chronic skin disorder causing reddish-orange patches) or other types of ichthyosis (a group of conditions causing dry, scaly skin) [1][4]. Finding the right answer through genetic testing is a major milestone that allows you to shift from searching for a cause to managing the condition effectively.

The Role of the ABHD5 Gene

To understand CDS, it helps to think of your cells as having a recycling system for fats. This system is governed by a gene called ABHD5.

  • The Mutation: CDS is an autosomal recessive disorder, meaning a person must inherit a pathogenic variant (mutation) of the ABHD5 gene from both parents to develop the condition [5].
  • The Fat Buildup: In healthy cells, the ABHD5 gene provides instructions for a protein that acts as a co-activator to help break down triglycerides (a type of fat) stored in tiny bubbles called lipid droplets [6][7]. When this gene isn’t working correctly, this breakdown process is impaired, and these droplets begin to pile up inside various cells throughout the body [8].
  • The Skin Barrier: In the skin, ABHD5 has an additional job. It helps create the lipids (oils) that form the “mortar” between your skin cells, which acts as a protective barrier [9]. When this process is disrupted, the skin cannot hold onto moisture or protect itself effectively, leading to the scaling and redness characteristic of ichthyosis [10].

Family Planning and Inheritance

Because CDS is autosomal recessive, genetic counseling is an important step. If both parents are carriers of an ABHD5 mutation, there is a 25% chance with each pregnancy that the child will have the condition, a 50% chance they will be a carrier, and a 25% chance they will be unaffected. A genetic counselor can discuss what this means for siblings, your own future children, and the role of carrier testing for relatives.

A Multisystem Condition

While the most visible sign of CDS is the skin, it is a systemic condition, meaning it can affect several parts of the body over time. It is distinct from its “sibling” condition, Neutral Lipid Storage Disease with Myopathy (NLSDM), which primarily affects the muscles and heart and usually does not involve the skin.

In CDS, the timing and severity of symptoms vary significantly from person to person [11]:

  • Skin: Most people are born with congenital ichthyosiform erythroderma, which appears as redness and fine white scales over most of the body [1].
  • Liver: As fat droplets build up in liver cells (steatosis), the liver may become enlarged. In some cases, this can progress to more serious issues like cirrhosis (scarring) [12][13].
  • Muscles: Some people experience mild muscle weakness or a breakdown of muscle tissue (myopathy) [11].
  • Senses and Organs: Over time, fat buildup can affect the eyes (leading to cataracts) or the ears (causing sensorineural hearing loss). Doctors may also monitor your thyroid, kidneys, and neurological health, as variable involvement in these areas has been reported [14].

Navigating Rare Disease Care

The emotional weight of a rare diagnosis is significant. It is normal to feel isolated or anxious about the future. Because CDS is so rare, you may find yourself “teaching” your own doctors about the condition.

While there is currently no cure, management focuses on protecting the skin barrier and monitoring the health of internal organs. You may read that specific dietary adjustments—such as restricting certain fats or supplementing with medium-chain triglycerides (MCTs)—may help liver or muscle symptoms. However, these are based on limited case reports and are not a universally established treatment [15][16]. Never start dietary restrictions independently. Restricting fats without supervision can cause dangerous calorie deficits or deficiencies in essential fatty acids and fat-soluble vitamins (A, D, E, K), particularly in growing children. Any dietary changes must be strictly supervised by a metabolic dietitian.

Building a multidisciplinary team is essential. This team often includes:

  1. Dermatologists to manage skin care.
  2. Hepatologists (liver specialists) to monitor liver health.
  3. Genetic Counselors to provide guidance for the family.
  4. Audiologists and Ophthalmologists for regular hearing and vision screenings.

By connecting with rare disease communities and staying proactive with monitoring, you can take control of your care journey.

Common questions in this guide

What is Chanarin-Dorfman syndrome?
Chanarin-Dorfman syndrome, also called neutral lipid storage disease with ichthyosis, is a very rare inherited condition. Changes in the ABHD5 gene impair the way cells handle stored fat, causing fat buildup and usually widespread scaly, reddened skin with possible effects on internal organs.
How is Chanarin-Dorfman syndrome diagnosed?
Genetic testing can identify disease-causing variants in both copies of the ABHD5 gene and is an important way to confirm the diagnosis. Ask for a copy of the complete genetic report and discuss how the findings fit with the skin and other symptoms.
How is Chanarin-Dorfman syndrome passed through families?
It follows an autosomal recessive pattern, meaning a child usually inherits a disease-causing ABHD5 variant from both parents. When both parents are carriers, each pregnancy has a 25% chance of the condition, a 50% chance of carrier status, and a 25% chance of being unaffected and not a carrier; a genetic counselor can explain testing options.
What parts of the body can Chanarin-Dorfman syndrome affect?
The skin is commonly affected from birth with widespread redness and fine scaling. Fat buildup may also affect the liver, muscles, eyes, and ears, causing problems such as liver enlargement or scarring, muscle weakness, cataracts, or hearing loss; thyroid, kidney, and nervous-system health may also need monitoring.
Which specialists may help manage this condition?
Care often involves a dermatologist for the skin, a liver specialist for liver health, and a genetic counselor for inheritance and family planning. Audiology, eye care, and metabolic nutrition specialists may also be involved to monitor hearing and vision and to guide nutrition safely.
Is there a cure for Chanarin-Dorfman syndrome?
There is currently no cure, so care focuses on protecting the skin barrier and checking for changes in the liver, muscles, hearing, vision, thyroid, kidneys, and nervous system. Dietary approaches such as medium-chain triglycerides have limited evidence and should be considered only with the treating team.
Should I restrict fat in the diet?
Do not start a low-fat diet or supplements on your own. Unsupervised changes can lead to too few calories or deficiencies in essential fats and vitamins, so a metabolic dietitian should tailor and monitor any dietary plan, especially for a growing child.

Get notified when new evidence is published on Neutral lipid storage disease with ichthyosis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    A novel mutation of ABHD5 gene in a Chanarin Dorfman patient with unusual dermatological findings.

    Eskiocak AH, Missaglia S, Moro L, et al.

    Lipids in health and disease 2019; (18(1)):232 doi:10.1186/s12944-019-1181-6.

    PMID: 31883530
  2. 2

    Recurrent N209* ABHD5 mutation in two unreported families with Chanarin Dorfman Syndrome.

    Tavian D, Durdu M, Angelini C, et al.

    European journal of translational myology 2021; (31(2)) doi:10.4081/ejtm.2021.9796.

    PMID: 33985321
  3. 3

    Jordans' anomaly in Chanarin-Dorfman syndrome.

    Sánchez-Cortés J, Gabaldó-Barrios X

    Advances in laboratory medicine 2025; (6(1)):118-121 doi:10.1515/almed-2024-0159.

    PMID: 40160390
  4. 4

    Case Report: Chanarin-Dorfman Syndrome: A Novel Homozygous Mutation in ABHD5 Gene in a Chinese Case and Genotype-Phenotype Correlation Analysis.

    Liang B, Huang H, Zhang J, et al.

    Frontiers in genetics 2022; (13()):847321 doi:10.3389/fgene.2022.847321.

    PMID: 35419035
  5. 5

    Maternal Isodisomy of Chromosome 3 Combined with a De Novo Mutation in the ABHD5 Gene Causes Autosomal Recessive Chanarin-Dorfman Syndrome.

    Kopp J, Has C, Hotz A, et al.

    Genes 2021; (12(8)) doi:10.3390/genes12081164.

    PMID: 34440338
  6. 6

    Critical roles for α/β hydrolase domain 5 (ABHD5)/comparative gene identification-58 (CGI-58) at the lipid droplet interface and beyond.

    Brown AL, Mark Brown J

    Biochimica et biophysica acta. Molecular and cell biology of lipids 2017; (1862(10 Pt B)):1233-1241 doi:10.1016/j.bbalip.2017.07.016.

    PMID: 28827091
  7. 7

    CGI-58: Versatile Regulator of Intracellular Lipid Droplet Homeostasis.

    Yu L, Li Y, Grisé A, Wang H

    Advances in experimental medicine and biology 2020; (1276()):197-222 doi:10.1007/978-981-15-6082-8_13.

    PMID: 32705602
  8. 8

    ABHD5-A Regulator of Lipid Metabolism Essential for Diverse Cellular Functions.

    Schratter M, Lass A, Radner FPW

    Metabolites 2022; (12(11)) doi:10.3390/metabo12111015.

    PMID: 36355098
  9. 9

    ABHD5 stimulates PNPLA1-mediated ω-O-acylceramide biosynthesis essential for a functional skin permeability barrier.

    Kien B, Grond S, Haemmerle G, et al.

    Journal of lipid research 2018; (59(12)):2360-2367 doi:10.1194/jlr.M089771.

    PMID: 30361410
  10. 10

    Skin Barrier Development Depends on CGI-58 Protein Expression during Late-Stage Keratinocyte Differentiation.

    Grond S, Radner FPW, Eichmann TO, et al.

    The Journal of investigative dermatology 2017; (137(2)):403-413 doi:10.1016/j.jid.2016.09.025.

    PMID: 27725204
  11. 11

    Long-term neuromuscular, cardiac and liver outcomes in an adult man affected with Chanarin-Dorfman syndrome.

    Noman K, Tridimas A, Lilleker JB, et al.

    Molecular genetics and metabolism reports 2025; (45()):101265 doi:10.1016/j.ymgmr.2025.101265.

    PMID: 41127218
  12. 12

    Chanarin-Dorfman Syndrome: A comprehensive review.

    Cakmak E, Bagci G

    Liver international : official journal of the International Association for the Study of the Liver 2021; (41(5)):905-914 doi:10.1111/liv.14794.

    PMID: 33455044
  13. 13

    Dorfman-Chanarin Syndrome: A Rare Cause of Metabolic Associated Fatty Liver Disease Related to Homozygosity of the Nonsense Mutation c.934C>T (p.R312*).

    Quelhas da Costa R, Laranjeira F, Duarte Ribeiro I, et al.

    GE Portuguese journal of gastroenterology 2022; (29(4)):284-290 doi:10.1159/000517103.

    PMID: 35979251
  14. 14

    Thyroid involvement in Chanarin-Dorfman syndrome in adults in the largest series of patients carrying the same founder mutation in ABHD5 gene.

    Louhichi N, Bahloul E, Marrakchi S, et al.

    Orphanet journal of rare diseases 2019; (14(1)):112 doi:10.1186/s13023-019-1095-4.

    PMID: 31118107
  15. 15

    Ichthyosis, cataracts, and motor delay in an infant: A case of Chanarin-Dorfman syndrome.

    Luu Y, Pithadia DJ, Teng J, Khuu P

    Pediatric dermatology 2023; (40(5)):879-881 doi:10.1111/pde.15258.

    PMID: 36709747
  16. 16

    An Adolescent with Chanarin-Dorfman Syndrome Presenting with Ichthyosis and Hepatic Steatosis.

    Habash N, Wang Y, Morava E, Ibrahim SH

    JPGN reports 2021; (2(4)):e137 doi:10.1097/PG9.0000000000000137.

    PMID: 37206464

This page about Chanarin-Dorfman syndrome is for informational purposes only and does not constitute medical advice. Your genetics, dermatology, liver, and metabolic care teams should interpret test results and guide treatment and dietary changes for you or your child.